Aurora Cannabis (NASDAQ:ACB – Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, February 5th. Analysts expect Aurora Cannabis to post earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Aurora Cannabis Price Performance
NASDAQ:ACB opened at $3.46 on Tuesday. The firm has a market cap of $189.82 million, a PE ratio of -4.55 and a beta of 1.85. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The company’s 50-day moving average price is $4.21 and its two-hundred day moving average price is $5.17.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. TD Cowen assumed coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They set a “buy” rating for the company. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- How to Invest in Small Cap Stocks
- Quiet Period Expirations Explained
- These Are the Dividend Stocks Insiders Bought in January
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.